Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Saxion University of Applied Sciences | OTHER |
| Deventer Ziekenhuis | OTHER |
| University of Twente | OTHER |
| Ziekenhuisgroep Twente |
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to develop and validate an XAI based model that predicts HF events and identifies modifiable con-tributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care in patients with heart failure. The main objectives of the study are:
Participants will wear a smartwatch for six months and perform an I-lead ecg with the smartwatch weekly.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Heart failure patients |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Heart failure (HF) event | HF event is defined as:
| From enrollment to the end of follow-up at 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Activity patterns | Activity patterns measured with the smartwatch | From enrollment to the end of follow-up at 6 months |
| Quality of life (QoL) | QoL measured with KCCQ-12 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients will be selected after HF hospitalization at three hospitals: Medisch Spectrum Twente (MST), Hospital Group Twente (ZGT), and Deventer hospital.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mark Schuuring, M.D., PhD., FESC, FEACVI, FHFA | Contact | 0534872105 | mark.schuuring@mst.nl |
Not provided
Not provided
Personal medical data
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
| Measured at baseline and at the end of follow-up at 6 months |
| Net promotor score (NPS) | NPS measures how likely patients are to recommend this technology to others. | At the end of follow-up at 6 months |